Macaca nemestrina (pig-tailed macaque): 105466747
Help
Entry
105466747 CDS
T08765
Symbol
CASP3
Name
(RefSeq) LOW QUALITY PROTEIN: caspase-3
KO
K02187
caspase 3 [EC:
3.4.22.56
]
Organism
mni
Macaca nemestrina (pig-tailed macaque)
Pathway
mni01524
Platinum drug resistance
mni04010
MAPK signaling pathway
mni04115
p53 signaling pathway
mni04148
Efferocytosis
mni04210
Apoptosis
mni04215
Apoptosis - multiple species
mni04623
Cytosolic DNA-sensing pathway
mni04650
Natural killer cell mediated cytotoxicity
mni04657
IL-17 signaling pathway
mni04668
TNF signaling pathway
mni04726
Serotonergic synapse
mni04932
Non-alcoholic fatty liver disease
mni04933
AGE-RAGE signaling pathway in diabetic complications
mni04936
Alcoholic liver disease
mni05010
Alzheimer disease
mni05012
Parkinson disease
mni05014
Amyotrophic lateral sclerosis
mni05016
Huntington disease
mni05020
Prion disease
mni05022
Pathways of neurodegeneration - multiple diseases
mni05132
Salmonella infection
mni05133
Pertussis
mni05134
Legionellosis
mni05145
Toxoplasmosis
mni05146
Amoebiasis
mni05152
Tuberculosis
mni05160
Hepatitis C
mni05161
Hepatitis B
mni05162
Measles
mni05163
Human cytomegalovirus infection
mni05164
Influenza A
mni05165
Human papillomavirus infection
mni05167
Kaposi sarcoma-associated herpesvirus infection
mni05168
Herpes simplex virus 1 infection
mni05169
Epstein-Barr virus infection
mni05170
Human immunodeficiency virus 1 infection
mni05200
Pathways in cancer
mni05203
Viral carcinogenesis
mni05205
Proteoglycans in cancer
mni05206
MicroRNAs in cancer
mni05210
Colorectal cancer
mni05222
Small cell lung cancer
mni05416
Viral myocarditis
mni05417
Lipid and atherosclerosis
Brite
KEGG Orthology (KO) [BR:
mni00001
]
09130 Environmental Information Processing
09132 Signal transduction
04010 MAPK signaling pathway
105466747 (CASP3)
04668 TNF signaling pathway
105466747 (CASP3)
09140 Cellular Processes
09141 Transport and catabolism
04148 Efferocytosis
105466747 (CASP3)
09143 Cell growth and death
04210 Apoptosis
105466747 (CASP3)
04215 Apoptosis - multiple species
105466747 (CASP3)
04115 p53 signaling pathway
105466747 (CASP3)
09150 Organismal Systems
09151 Immune system
04623 Cytosolic DNA-sensing pathway
105466747 (CASP3)
04650 Natural killer cell mediated cytotoxicity
105466747 (CASP3)
04657 IL-17 signaling pathway
105466747 (CASP3)
09156 Nervous system
04726 Serotonergic synapse
105466747 (CASP3)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
105466747 (CASP3)
05206 MicroRNAs in cancer
105466747 (CASP3)
05205 Proteoglycans in cancer
105466747 (CASP3)
05203 Viral carcinogenesis
105466747 (CASP3)
09162 Cancer: specific types
05210 Colorectal cancer
105466747 (CASP3)
05222 Small cell lung cancer
105466747 (CASP3)
09172 Infectious disease: viral
05170 Human immunodeficiency virus 1 infection
105466747 (CASP3)
05161 Hepatitis B
105466747 (CASP3)
05160 Hepatitis C
105466747 (CASP3)
05164 Influenza A
105466747 (CASP3)
05162 Measles
105466747 (CASP3)
05168 Herpes simplex virus 1 infection
105466747 (CASP3)
05163 Human cytomegalovirus infection
105466747 (CASP3)
05167 Kaposi sarcoma-associated herpesvirus infection
105466747 (CASP3)
05169 Epstein-Barr virus infection
105466747 (CASP3)
05165 Human papillomavirus infection
105466747 (CASP3)
09171 Infectious disease: bacterial
05132 Salmonella infection
105466747 (CASP3)
05133 Pertussis
105466747 (CASP3)
05134 Legionellosis
105466747 (CASP3)
05152 Tuberculosis
105466747 (CASP3)
09174 Infectious disease: parasitic
05146 Amoebiasis
105466747 (CASP3)
05145 Toxoplasmosis
105466747 (CASP3)
09164 Neurodegenerative disease
05010 Alzheimer disease
105466747 (CASP3)
05012 Parkinson disease
105466747 (CASP3)
05014 Amyotrophic lateral sclerosis
105466747 (CASP3)
05016 Huntington disease
105466747 (CASP3)
05020 Prion disease
105466747 (CASP3)
05022 Pathways of neurodegeneration - multiple diseases
105466747 (CASP3)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
105466747 (CASP3)
05416 Viral myocarditis
105466747 (CASP3)
09167 Endocrine and metabolic disease
04936 Alcoholic liver disease
105466747 (CASP3)
04932 Non-alcoholic fatty liver disease
105466747 (CASP3)
04933 AGE-RAGE signaling pathway in diabetic complications
105466747 (CASP3)
09176 Drug resistance: antineoplastic
01524 Platinum drug resistance
105466747 (CASP3)
09180 Brite Hierarchies
09181 Protein families: metabolism
01002 Peptidases and inhibitors [BR:
mni01002
]
105466747 (CASP3)
Enzymes [BR:
mni01000
]
3. Hydrolases
3.4 Acting on peptide bonds (peptidases)
3.4.22 Cysteine endopeptidases
3.4.22.56 caspase-3
105466747 (CASP3)
Peptidases and inhibitors [BR:
mni01002
]
Cysteine peptidases
Family C14: caspase family
105466747 (CASP3)
BRITE hierarchy
SSDB
Ortholog
Paralog
GFIT
Motif
Pfam:
Peptidase_C14
SICA_beta
Motif
Other DBs
NCBI-GeneID:
105466747
NCBI-ProteinID:
XP_024643900
Ensembl:
ENSMNEG00000018721
LinkDB
All DBs
Position
Unknown
AA seq
274 aa
AA seq
DB search
MENTENSVDSKSIKSLEPKIIHGSKSVDSGISLDNSYKMDYPEMGLCIIINNKNFHKSTG
MASRSGTDVDAANLRETFINLKYEVRNKNDLTREEIVDDVSKEDHSXRSSFVCVLLSHGE
EGIIFGTNGPLDLKKITSFFRGDCCRSLTGKPKLFIIQACRGTELDCGIETDSGVEDDMA
CHKIPVEADFLYAYSTAPGYYSWRNSKDGSWFIQSLCAMLKQYADKLEFMHILTRVNRKV
ATEFESFSLDATFHAKKXIPCIVSMLTKELYFYH
NT seq
825 nt
NT seq
+upstream
nt +downstream
nt
atggagaacactgaaaactcagtggattcaaaatccattaaaagtttggaaccaaaaatc
atacatggaagcaaatcagtggactctggaatatccctggacaacagttataaaatggat
tatcctgagatgggtttatgtataataattaataataagaattttcataaaagcactgga
atggcatctcggtctggtacagatgttgatgcagcaaacctcagggaaacattcataaac
ttgaaatatgaagtcaggaataaaaacgatcttacacgtgaagaaattgtggatgatgtt
tctaaagaagatcacagcnaaaggagcagttttgtttgtgtgcttctgagccatggtgaa
gaaggaataatttttggaacaaatggacctcttgacctgaaaaaaattacaagctttttc
agaggggattgttgtagaagtctaactggaaaacccaaacttttcattattcaggcctgc
cgtggcacagaactggactgtggcattgagacagacagtggtgttgaggatgacatggcg
tgtcataaaatcccagtggaggccgacttcttgtatgcatactccacagcacctggttat
tattcttggcgaaattcaaaggatggctcctggttcatccagtcgctttgtgccatgctg
aaacagtacgccgacaagcttgaatttatgcacattcttacccgggttaaccgaaaggtg
gcaacagaatttgagtccttttcccttgatgctacttttcatgcaaagaaatagattcca
tgtattgtttccatgctcacaaaagaactgtatttttatcactaa
DBGET
integrated database retrieval system